Announce Date | 01/30/2025 |
EPS Normalized Actual | $0.64 (Beat by $0.57247) |
EPS GAAP Actual | $0.64 (Beat by $0.57247) |
Revenue Actual | $30.756B |
Revenue Surprise | Beat by $30756M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 19.1 | 5.48 | 15.59768 | 23.19634 | 1 |
Dec 2028 | 6.95 | 15.06 | 5.84933 | 7.63428 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.87 | 0.87 | 30.756B | -15.15% | 30756M |
FQ3 2024 (Sep 2024) | 1.14 | 1.14 | 32.876B | -115.32% | 32876M |
FQ2 2024 (Jun 2024) | 2.71 | 2.71 | 34.463B | -85.53% | 34463M |
FQ1 2024 (Mar 2024) | 3.76 | 3.76 | 59.441B | 38.7% | 59441M |
FQ4 2023 (Dec 2023) | 3.56 | 3.56 | 35.414B | -17.88% | 35414M |
FQ3 2023 (Sep 2023) | 7.51 | 7.51 | 70.789B | 37.2% | 70789M |
FQ2 2023 (Jun 2023) | 5.43 | 5.43 | 63.939B | 19.23% | 63939M |
FQ1 2023 (Mar 2023) | 8.29 | 8.29 | 36.439B | 100% | 36439M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 0.2901 | -- | 0.23206 | 0.35554 | 5 |
FQ3 2028 (Sep 2028) | 2.8309 | -- | 2.26456 | 3.46948 | 4 |
FQ2 2028 (Jun 2028) | 3.2855 | -- | 2.62821 | 4.02663 | 5 |
FQ1 2028 (Mar 2028) | -0.4591 | -- | -0.56266 | -0.36725 | 4 |
FQ4 2027 (Oct 2027) | 5.1911 | -- | 4.65967 | 5.58477 | 4 |
FQ3 2027 (Jul 2027) | 3.4419 | -- | 3.08954 | 3.70292 | 4 |
FQ2 2027 (Jun 2027) | 2.36152 | -- | 1.96573 | 2.72778 | 4 |
FQ1 2027 (Mar 2027) | 1.6637 | -- | 1.38486 | 1.92173 | 4 |
FQ4 2026 (Oct 2026) | 4.01023 | -- | 3.59969 | 4.31435 | 4 |
FQ3 2026 (Jul 2026) | 3.94487 | -- | 3.54102 | 4.24403 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 66.6B | -- | 56.35B | 78.15B | 3 |
FQ3 2028 (Sep 2028) | 63.89B | -- | 54.06B | 74.97B | 3 |
FQ2 2028 (Jun 2028) | 61.29B | -- | 51.85B | 71.92B | 3 |
FQ1 2028 (Mar 2028) | 58.79B | -- | 49.74B | 68.99B | 3 |
FQ4 2027 (Oct 2027) | 106.37B | -- | 98B | 112.58B | 2 |
FQ3 2027 (Jul 2027) | 102.04B | -- | 94.01B | 107.99B | 2 |
FQ2 2027 (Jun 2027) | 159.36B | -- | 138.82B | 178.38B | 2 |
FQ1 2027 (Mar 2027) | 150.51B | -- | 131.11B | 168.47B | 2 |
FQ4 2026 (Oct 2026) | 28.14B | -- | 25.92B | 29.78B | 2 |
FQ3 2026 (Jul 2026) | 27.83B | -- | 25.64B | 29.45B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.87 | 0.87 | 100% | |
FQ3 2024 (Sep 2024) | 1.14 | 1.14 | 100% | |
FQ2 2024 (Jun 2024) | 2.71 | 2.71 | 100% | |
FQ1 2024 (Mar 2024) | 3.76 | 3.76 | 100% | |
FQ4 2023 (Dec 2023) | 3.56 | 3.56 | 100% | |
FQ3 2023 (Sep 2023) | 7.51 | 7.51 | 100% | |
FQ2 2023 (Jun 2023) | 5.43 | 5.43 | 100% | |
FQ1 2023 (Mar 2023) | 8.29 | 8.29 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $30.76B | $30756M | 100% |
FQ3 2024 (Sep 2024) | $0B | $32.88B | $32876M | 100% |
FQ2 2024 (Jun 2024) | $0B | $34.46B | $34463M | 100% |
FQ1 2024 (Mar 2024) | $0B | $59.44B | $59441M | 100% |
FQ4 2023 (Dec 2023) | $0B | $35.41B | $35414M | 100% |
FQ3 2023 (Sep 2023) | $0B | $70.79B | $70789M | 100% |
FQ2 2023 (Jun 2023) | $0B | $63.94B | $63939M | 100% |
FQ1 2023 (Mar 2023) | $0B | $36.44B | $36439M | 100% |